This article is more than 5 years old. Information may no longer be current.
Memorial Sloan Kettering Cancer Center names department chairman
Click Here to Manage Email Alerts
Philip W. Kantoff, MD, has been named chairman of the department of medicine at Memorial Sloan Kettering Cancer Center.
“We are ecstatic to have been able to recruit Dr. Kantoff to lead MSK’s already superb department of medicine. I am eager to work with him to extend our vision for patient care, academic growth, and research excellence,” Jose Baselga, MD, PhD, Memorial Sloan Kettering’s physician in chief, said in a press release. “His astute leadership qualities and strong record of clinical and research experience will prove invaluable as we work together to usher this institution into the future and continue our tradition of excellence.”
Philip W. Kantoff
Kantoff spent the past 28 years with Dana-Farber Cancer Institute and Harvard Medical School. He served as director of Lank Center for Genitourinary Oncology, chief of the division of solid tumor oncology, vice chair of the department of medical oncology and chair of the executive committee on clinical research at Dana-Farber Cancer Institute. He also served as professor of medicine at Harvard Medical School, where his research program focused on the molecular basis of genitourinary cancers.
Kantoff led the Dana-Farber/Harvard Cancer Center prostate cancer program. He also serves as chairman of the Global Treatment Science Network of the Prostate Cancer Foundation.
George J. Bosl
Kantoff succeeds George J. Bosl, MD, who served as chairman of the department of medicine at Memorial Sloan Kettering Cancer Center since 1997.
“Memorial Sloan Kettering is indebted to Dr. Bosl for his years of service,” Baselga said. “He led the institution through many important years of growth while consistently remaining focused on the importance of both scientific achievement and patient care.”